Core Points - Vili Medical (603309) closed at 12.93 yuan on July 11, 2025, up 0.7% from the previous week [1] - The company's total market capitalization is 3.787 billion yuan, ranking 90th out of 126 in the medical device sector and 3795th out of 5149 in the A-share market [1] Company Announcements - Vili Medical's wholly-owned subsidiary, Hainan Vili, received a Class II medical device registration certificate for a single-use hydrophilic coated visual nasogastric tube [1] - The product is designed for delivering nutrients, gastric decompression, and flushing, consisting of a feeding connector, gastric tube, and a bullet head with a camera [1] - The registration certificate was issued on July 7, 2025, and is valid until July 6, 2030 [1] - Currently, there are no similar products available in the domestic market, which may enhance the subsidiary's product variety and market competitiveness [1] - Although the registration is expected to positively impact the company's operations, the product has not yet been marketed, and its short-term effect on financial performance is minimal [1] - The actual sales performance will depend on future marketing efforts, and the specific impact on the company's future financial results remains uncertain [1]